Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Richard J. Johnson, George L. Bakris, Claudio Borghi, et al.
American Journal of Kidney Diseases (2018) Vol. 71, Iss. 6, pp. 851-865
Open Access | Times Cited: 533

Showing 1-25 of 533 citing articles:

Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve, Elaine M. Pascoe, Anushree Tiku, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 26, pp. 2504-2513
Open Access | Times Cited: 360
Gout epidemiology and comorbidities
Jasvinder A. Singh, Angelo Gaffo
Seminars in Arthritis and Rheumatism (2020) Vol. 50, Iss. 3, pp. S11-S16
Open Access | Times Cited: 310
Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
Wei Yu, Jidong Cheng
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 254
Re‐evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs
Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, et al.
EFSA Journal (2023) Vol. 21, Iss. 4
Open Access | Times Cited: 239
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Mihai-Emil Gherghina, Ileana Peride, Mirela Ţigliş, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3188-3188
Open Access | Times Cited: 237
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Leo A. B. Joosten, Tania O. Crişan, Petter Bjornstad, et al.
Nature Reviews Rheumatology (2019) Vol. 16, Iss. 2, pp. 75-86
Open Access | Times Cited: 228
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
Fouad T. Chebib, Ronald D. Perrone, Arlene B. Chapman, et al.
Journal of the American Society of Nephrology (2018) Vol. 29, Iss. 10, pp. 2458-2470
Open Access | Times Cited: 210
The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies
Jing Wang, Yong Chen, Hao Zhong, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 14, pp. 3979-3989
Closed Access | Times Cited: 210
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
Yuka Sato, Daniel I. Feig, Austin G. Stack, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 12, pp. 767-775
Closed Access | Times Cited: 163
Uric Acid and Hypertension: An Update With Recommendations
Laura Gabriela Sánchez‐Lozada, Bernardo Rodríguez‐Iturbe, Eric E. Kelley, et al.
American Journal of Hypertension (2020) Vol. 33, Iss. 7, pp. 583-594
Open Access | Times Cited: 161
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Sidar Çöpür, Atalay Demiray, Mehmet Kanbay
European Journal of Internal Medicine (2022) Vol. 103, pp. 4-12
Closed Access | Times Cited: 154
U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia
William T. Crawley, Cyprien G. Jungels, Kurt R. Stenmark, et al.
Redox Biology (2022) Vol. 51, pp. 102271-102271
Open Access | Times Cited: 127
Enzyme Mimics for Engineered Biomimetic Cascade Nanoreactors: Mechanism, Applications, and Prospects
Xianlong Zhang, Guoliang Li, Guang Chen, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 50
Closed Access | Times Cited: 122
Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach
Che-Jung Chang, Dana Boyd Barr, P. Barry Ryan, et al.
Environment International (2021) Vol. 158, pp. 106964-106964
Open Access | Times Cited: 111
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 97
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Lin Du, Zong Yao, H. Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 90
The potential of probiotics in the amelioration of hyperuricemia
Hongyuan Zhao, Zhaoxin Lu, Yingjian Lu
Food & Function (2022) Vol. 13, Iss. 5, pp. 2394-2414
Closed Access | Times Cited: 73
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function
Danii L. S. Suijk, Michaël J.B. van Baar, Erik J.M. van Bommel, et al.
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 5, pp. 663-671
Open Access | Times Cited: 70
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Xi Lu, Qingxing Xie, Xiaohui Pan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Update in uric acid, hypertension, and cardiovascular diseases
Masanari Kuwabara, Takahide Kodama, Ryusuke Ae, et al.
Hypertension Research (2023) Vol. 46, Iss. 7, pp. 1714-1726
Closed Access | Times Cited: 46
Alistipes indistinctus-derived hippuric acid promotes intestinal urate excretion to alleviate hyperuricemia
Yingxi Xu, Ludi Liu, Jiang-Yuan Zhu, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 3, pp. 366-381.e9
Closed Access | Times Cited: 26
Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout
Shuaiwei Song, Xintian Cai, Junli Hu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 23
Investigation of the connection between triglyceride-glucose (TyG) index and the risk of acute kidney injury in septic patients - a retrospective analysis utilizing the MIMIC-IV database
Pirun Zhang, Wei Zhang, Han Yan, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access | Times Cited: 2
The association between body roundness index and new-onset hyperuricemia in Chinese population: the Kailuan cohort study
Xi Cai, Naihui Zhao, Xue‐Mei Yang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach
Tilal Elsaman, Magdi Awadalla Mohamed
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 126-126
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top